One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome

Clinical trial NCT00748566 · TERMINATED

Trial details

NCT number

NCT00748566

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Status

TERMINATED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2008-12-01

Primary completion

2012-05-01

Enrollment

172

View on ClinicalTrials.gov